Vectorite Biomedical Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 206.330 million compared to TWD 144.438 million a year ago. Operating loss was TWD 67.716 million compared to TWD 53.973 million a year ago. Net loss was TWD 30.323 million compared to TWD 62.695 million a year ago. Basic loss per share was TWD 0.72 compared to TWD 1.55 a year ago.